
Abbott Labs (ABT) Stock Forecast & Price Target
Abbott Labs (ABT) Analyst Ratings
Bulls say
Abbott Laboratories is expected to continue its strong performance driven by its diverse product portfolio and expanding presence in high-growth areas such as diabetes, structural heart, and diagnostics. The company's leading market position, successful commercial strategy, and robust pipeline provide a strong foundation for future growth. Additionally, the company's focus on driving affordability and expanding into emerging markets will contribute to its global dominance.
Bears say
Abbott Laboratories is a diversified healthcare company with a strong international presence, but concerns about organic growth, unfavorable changes in healthcare regulation, pricing, and reimbursement, and potential product safety concerns and product liability are key reasons for its negative outlook. Despite management expressing confidence in the company's ability to grow and its effective capital deployment strategy, the longer-term goal of delivering high-single-digit organic sales growth and double-digit EPS growth may not be achievable in the current macro climate. Additionally, Abbott trades at a premium valuation compared to its large-cap peers, making it vulnerable to any negative developments.
This aggregate rating is based on analysts' research of Abbott Labs and is not a guaranteed prediction by Public.com or investment advice.
Abbott Labs (ABT) Analyst Forecast & Price Prediction
Start investing in Abbott Labs (ABT)
Order type
Buy in
Order amount
Est. shares
0 shares